Interim analysis of the Portal extension trial evaluating the long-term safety and efficacy of the Port Delivery System with ranibizumab (PDS) in neovascular age-related macular degeneration (nAMD)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要